会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 7. 发明公开
    • PROTEASE INHIBITORS
    • 蛋白酶抑制剂
    • EP1140897A1
    • 2001-10-10
    • EP99968936.7
    • 1999-12-21
    • SmithKline Beecham Corporation
    • MARQUIS, Robert, Wells, Jr.VEBER, Daniel, Frank
    • C07D401/02C07D401/14C07D225/02A61K31/33A61K31/44A61K31/47A61P19/02A61P19/10
    • C07D401/12C07D225/02
    • The present invention provides compounds of formula (I) and pharmaceutically acceptable salts, hydrates and solvates thereof which inhibit proteases, including cathepsin K, pharmaceutical compositions of such compounds, novel intermediates of such compounds, and methods of treating diseases of excessive bone loss or cartilage or matrix degradation, including osteoporosis, gingival disease including gingivitis and periodontitis; arthritis, more specifically osteoarthritis and rheumatoid arthritis; Paget's disease; hypercalcemia or malignancy and metabolic bone disease, comprising inhibiting said bone loss or excessive cartilage or matrix degradation by administering to a patient in need thereof a compound of the present invention.
    • 本发明提供了式(I)化合物及其药学上可接受的盐,水合物和溶剂化物,其抑制蛋白酶,包括组织蛋白酶K,这些化合物的药物组合物,这类化合物的新中间体,以及治疗过量骨丢失或软骨疾病的方法 或基质降解,包括骨质疏松症,包括牙龈炎和牙周炎的牙龈疾病; 关节炎,更具体地说是骨关节炎和类风湿性关节炎; 佩吉特氏病; 高钙血症或恶性肿瘤以及代谢性骨病,包括通过向有需要的患者施用本发明的化合物来抑制所述骨丢失或过度软骨或基质降解。